Cases & Deals

Nanobiotix completes €14.2 million (US$18.4 million) IPO

Clients Nanobiotix

Jones Day advised Nanobiotix, along with underwriters CM-CIC Securities, Gilbert Dupont, and BIL Finance, in connection with the €14.2 million (US$18.4 million) initial public offering and listing on the regulated market of NYSE Euronext in Paris, of Nanobiotix, a pioneer and leader in nanomedicine that has developed a revolutionary concept dedicated to the local treatment of cancer.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.